Sleeping Beauty-mediated correction of Fanconi anemia type C

Kendra A. Hyland, Erik R. Olson, Karl J. Clark, Elena L. Aronovich, Perry B. Hackett, Bruce R. Blazar, Jakub Tolar, R. Scott Mcivor

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Background: The Sleeping Beauty (SB) transposon system can insert defined sequences into chromosomes to direct the extended expression of therapeutic genes. Our goal is to develop the SB system for nonviral complementation of Fanconi anemia (FA), a rare autosomal recessive disorder accompanied by progressive bone marrow failure. Methods: We used a CytoPulse electroporation system (CytoPulse, Glen Burnie, MD, USA) to introduce SB transposons into human lymphoblastoid cells (LCL) derived from both Fanconi anemia type C (FA-C) defective and normal patients. Correction of the FA-C defect was assessed by resistance to mitomycin C, a DNA-crosslinking agent. Results: Culture of both cell types with the antioxidant N-acetyl- l-cysteine improved cell viability after electroporation. Co-delivery of enhanced green fluorescent protein (GFP) transposon with SB100X transposase-encoding plasmid supported a 50- to 90-fold increase in stable GFP expression compared to that observed in the absence of SB100X for normal LCL, but in FA-C defective LCL SB100X enhancement of stable GFP-expression was a more moderate five- to 13-fold. SB-mediated integration and expression of the FA-C gene was demonstrated by the emergence of a mitomycin C-resistant population bearing characteristic transposon-chromosome junction sequences and exhibiting a mitomycin dose response identical to that of normal LCL. Conclusions: The SB transposon system achieved stable expression of therapeutic FA-C genes, complementing the genetic defect in patient-derived cells by nonviral gene transfer.

Original languageEnglish (US)
Pages (from-to)462-469
Number of pages8
JournalJournal of Gene Medicine
Volume13
Issue number9
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Keywords

  • Fanconi anemia
  • Gene therapy
  • Nonviral
  • Sleeping Beauty

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Sleeping Beauty-mediated correction of Fanconi anemia type C'. Together they form a unique fingerprint.

  • Cite this

    Hyland, K. A., Olson, E. R., Clark, K. J., Aronovich, E. L., Hackett, P. B., Blazar, B. R., Tolar, J., & Scott Mcivor, R. (2011). Sleeping Beauty-mediated correction of Fanconi anemia type C. Journal of Gene Medicine, 13(9), 462-469. https://doi.org/10.1002/jgm.1589